Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218361 · ClinicalTrials.gov registry record
Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 16
- Enrollment target
NCT00218361 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 16 participants.
The verdict
NCT00218361 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether knowledge of post-session hydromorphone (HYD) availability reduces drug seeking behavior in heroin dependent individuals.
Interventions
- DRUG Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2005-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218361
The ClinicalTrials.gov registry entry for NCT00218361 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hydromorphone is the first listed.
NCT00218361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218361 about?
NCT00218361 is a clinical study titled "Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals". The purpose of this study is to determine whether knowledge of post-session hydromorphone (HYD) availability reduces drug seeking behavior in heroin dependent individuals.
What is the current status of trial NCT00218361?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2005-08.
What interventions are being tested in trial NCT00218361?
The interventions under investigation include: Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT00218361?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.